Has David Schultz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,028,916 in general payments to David Schultz, MD across 1,618 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Schultz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Schultz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Schultz, MD

Family Medicine · Evansville, INNPI 1912987363

Payments from drug & device makers

$3,028,916in general payments, 2019–2025

Across 1,618 payments — averaging $1872.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$2.9M
AstraZeneca$88K
GSK$40K
Otsuka America Pharmaceutical, Inc.$3K
AbbVie$3K
Amgen$3K
plus $11K from 54 others

$733,213in research payments, 2019–2025

Across 9 payments — averaging $81,468 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$733K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	46	$2,882,028
AstraZeneca	42	$87,503
GSK	80	$39,803
Otsuka America Pharmaceutical, Inc.	60	$3,225
AbbVie(2 entities)	281	$2,841
Amgen(2 entities)	245	$2,664
Novo Nordisk	96	$1,101
Novartis	111	$960
Pfizer	97	$904
Merck	53	$768
Lundbeck LLC	47	$648
Lilly USA, LLC	47	$556
Teva Pharmaceuticals USA, Inc.	50	$473
Bayer	32	$384
Boehringer Ingelheim	30	$380
Takeda Pharmaceuticals U.S.A., Inc.	28	$360
Astellas Pharma US Inc	20	$314
Supernus Pharmaceuticals, Inc.	22	$311
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	19	$300
Vanda Pharmaceuticals Inc.	12	$289
Axsome Therapeutics, Inc.	15	$286
Johnson & Johnson	16	$262
Amarin Pharma, Inc.	35	$258
Biohaven Pharmaceutical Holding Company Ltd.	15	$230
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$211
Dexcom, Inc.	10	$196
Corium, LLC	12	$144
Kowa Pharmaceuticals America, Inc.	9	$141
Aimmune Therapeutics, Inc.	6	$130
Eisai Inc.	5	$110
Biohaven Pharmaceuticals, Inc.	7	$106
Ironshore Pharmaceuticals Inc.	4	$85
Sumitomo Pharma America, Inc.	4	$80
Phathom Pharmaceuticals, Inc.	4	$64
Alkermes, Inc.	3	$57
Avanir Pharmaceuticals, Inc.	4	$54
Medtronic	2	$52
Exact Sciences	3	$48
Ardelyx, Inc.	3	$48
Genentech USA, Inc.	3	$46
Intuitive Surgical	1	$39
Idorsia Pharmaceuticals US Inc	2	$33
E.r. Squibb & Sons, L.L.C.	2	$32
Shire North American Group Inc	2	$30
Sanofi-aventis U.S. LLC	2	$29
Amneal Pharmaceuticals LLC	2	$28
Sanofi Pasteur Inc.	1	$28
Neurocrine Biosciences, Inc.	1	$28
Nestle Healthcare Nutrition Inc.	2	$27
Vertex	1	$22
Mylan Specialty L.p.	1	$21
Dermira, Inc.	1	$20
Insulet Corporation	1	$19
Boston Scientific	1	$19
Pulmonx Corporation	1	$18
Ironwood Pharmaceuticals, Inc	1	$17
Abbott	1	$17
Verona Pharma, Inc.	1	$15
Circassia Inc.	1	$15
Inspire Medical Systems, Inc.	1	$14

How this compares

$3,028,916 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$268,469

Medicare patients

704

Services billed

3,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Evansville

J Christopher SartoreEvansville$3.9M
Hubert ReyesEvansville$3.2M
Alexander Dela LlanaEvansville$1.6M
David BrougherEvansville$556K
Anthony InzerelloEvansville$338K
James GutmannEvansville$311K
Randall StoltzEvansville$248K
William SmithEvansville$150K
Carol GoodmanEvansville$123K
Lauren VeazeyEvansville$71K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →